drugset / Trial / NCT04469023
Late Phase II Study of TS-142 in Patients with Insomnia
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, double-blind, multi-center, placebo-controlled, parallel-group exploratory study in patients with insomnia.
Timeline
- Start
- 2020-09-09
- Primary completion
- 2021-11-16
- Completion
- 2021-11-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TS-142 | Small molecule | 2.5 mg | Oral |
| Subject | TS-142 | Small molecule | 5 mg | Oral |
| Subject | TS-142 | Small molecule | 10 mg | Oral |